EuropaBio's World Cancer Day call for better access

The European Association for Bioindustries (EuropaBio) has called for greater access to new biotechnology drugs for cancer patients worldwide,  on the occasion of the International Union Against Cancer's (UICC)  fourth World Cancer Day, February 4.

The EuropaBio's secretary general, Willy De Greef, said in a statement:  "cancer patients can...only benefit from new treatments if they have  access to them. Biotech treatments have already shown great promise in  targeting cancer more effectively and offering patients an improved  quality of life. World Cancer Day gives us the chance to focus on the  plight of the cancer patient and engages us to continue our work, both  in the development of new or improved medications and in ensuring that  patients gain as quick as possible access to these lifesaving treatments  once they have received their marketing authorization."